天美传媒官网

>

Post-transcriptional modifications on tRNA fragments confer functional changes to high-density lipoproteins in atherosclerosis

Semler, E. M., Michell, D. L., Kingsley, P. J., Ramirez, M. A., Massick, C., Castleberry, M., Doran, A. C., Carr, J. J., Marnett, L., Sheng, Q., Linton, M. F., & Vickers, K. C. (2026).听.听Atherosclerosis,听412, 120584.听

Chemical modifications on RNA, called聽epitranscriptomic modifications, help control how RNA works in our cells. Small RNA fragments, known as聽tRNA-derived fragments (tDRs), can carry these modifications from their parent RNA. Some of these modified RNAs travel through the blood inside聽high-density lipoproteins (HDL), the same particles that carry 鈥済ood cholesterol.鈥 These HDL-associated RNAs (HDL-sRNAs) can influence聽immune responses聽and may play a role in聽atherosclerotic cardiovascular disease (ASCVD).

In this study, we compared HDL-sRNAs from healthy people and patients with advanced ASCVD. Using methods like聽LC-MS/MS,听ARM-seq, and聽qPCR, we found that HDL from ASCVD patients had more RNA modifications. We identified a specific fragment,听tDR-ArgACG, carrying a modification called聽1-methyladenosine (m1A), which was more common in ASCVD. When these modified RNAs entered聽macrophages, immune cells that drive inflammation in arteries, they changed gene activity, including increasing聽TMEM123, a protein that helps immune cells move and stick to tissues. Experiments showed that HDL carrying m1A-tDR-ArgACG boosted TMEM123 in macrophages, and blocking the m1A modification reduced this effect.

These findings suggest that HDL can deliver modified RNAs to immune cells, triggering聽inflammation聽in atherosclerotic plaques. This reveals a new way that HDL-sRNAs may contribute to cardiovascular disease and points to potential targets for therapy.

Fig. 1聽CAC聽HDL induces non-classical activation and select immune response pathway and gene expression changes in macrophages聽(A) Volcano plot depicting log10 p-adjusted (Q)-value versus log2 fold changes for all differentially expressed (鈮2.0 absolute fold change) genes in BMDM’s treated with CAC聽+聽HDL or Ctr-HDL (n聽=聽3). (B) EGR1-containing gene set pathway analyses (Meta Core) enrichment, ranked by -log10(p-value) with false discovery rate (FDR) shown. (C) mRNA expression by qPCR displaying fold change from BMDMs treated with Ctr-HDL (n聽=聽9) and CAC+HDL (n聽=聽14). Statistical analysis assessed by Mann-Whitney聽U聽test. Data are presented as mean聽+s.e.m., 鈭辫听&濒迟;听0.05.